nodes	percent_of_prediction	percent_of_DWPC	metapath
Gentamicin—LRP2—prostate cancer	0.757	1	CbGaD
Gentamicin—LRP2—prostate gland—prostate cancer	0.00974	0.35	CbGeAlD
Gentamicin—LRP2—epithelium—prostate cancer	0.00716	0.257	CbGeAlD
Gentamicin—LRP2—renal system—prostate cancer	0.00664	0.239	CbGeAlD
Gentamicin—LRP2—testis—prostate cancer	0.00429	0.154	CbGeAlD
Gentamicin—SLC22A6—Conjugated Estrogens—prostate cancer	0.00173	1	CbGbCtD
Gentamicin—LRP2—Disease—GSTO1—prostate cancer	0.000145	0.00156	CbGpPWpGaD
Gentamicin—Confusional state—Estradiol—prostate cancer	0.000144	0.00119	CcSEcCtD
Gentamicin—LRP2—Metabolism—PDHA1—prostate cancer	0.000143	0.00154	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTA3—prostate cancer	0.000143	0.00154	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—UCP3—prostate cancer	0.000143	0.00154	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—TCN2—prostate cancer	0.000143	0.00154	CbGpPWpGaD
Gentamicin—Urticaria—Goserelin—prostate cancer	0.000143	0.00118	CcSEcCtD
Gentamicin—Anaphylactic shock—Estradiol—prostate cancer	0.000142	0.00118	CcSEcCtD
Gentamicin—Body temperature increased—Goserelin—prostate cancer	0.000142	0.00118	CcSEcCtD
Gentamicin—Muscular weakness—Prednisone—prostate cancer	0.000142	0.00118	CcSEcCtD
Gentamicin—Urticaria—Conjugated Estrogens—prostate cancer	0.000141	0.00117	CcSEcCtD
Gentamicin—Weight decreased—Capecitabine—prostate cancer	0.000141	0.00117	CcSEcCtD
Gentamicin—Neuropathy peripheral—Docetaxel—prostate cancer	0.000141	0.00117	CcSEcCtD
Gentamicin—Convulsion—Mitoxantrone—prostate cancer	0.000141	0.00117	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—WNT4—prostate cancer	0.000141	0.00151	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—JUP—prostate cancer	0.000141	0.00151	CbGpPWpGaD
Gentamicin—Vascular purpura—Epirubicin—prostate cancer	0.000141	0.00117	CcSEcCtD
Gentamicin—Body temperature increased—Conjugated Estrogens—prostate cancer	0.000141	0.00117	CcSEcCtD
Gentamicin—Hypertension—Mitoxantrone—prostate cancer	0.00014	0.00116	CcSEcCtD
Gentamicin—Stomatitis—Docetaxel—prostate cancer	0.00014	0.00116	CcSEcCtD
Gentamicin—Vomiting—Ethinyl Estradiol—prostate cancer	0.000139	0.00115	CcSEcCtD
Gentamicin—Arthralgia—Mitoxantrone—prostate cancer	0.000138	0.00115	CcSEcCtD
Gentamicin—Rash—Ethinyl Estradiol—prostate cancer	0.000138	0.00114	CcSEcCtD
Gentamicin—Dermatitis—Ethinyl Estradiol—prostate cancer	0.000138	0.00114	CcSEcCtD
Gentamicin—Alopecia—Etoposide—prostate cancer	0.000137	0.00114	CcSEcCtD
Gentamicin—Headache—Ethinyl Estradiol—prostate cancer	0.000137	0.00113	CcSEcCtD
Gentamicin—LRP2—Disease—P4HB—prostate cancer	0.000137	0.00147	CbGpPWpGaD
Gentamicin—LRP2—Disease—EIF2AK2—prostate cancer	0.000137	0.00147	CbGpPWpGaD
Gentamicin—LRP2—Disease—RPL10—prostate cancer	0.000137	0.00147	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—SLC22A3—prostate cancer	0.000137	0.00147	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—HSD3B1—prostate cancer	0.000137	0.00147	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Capecitabine—prostate cancer	0.000137	0.00113	CcSEcCtD
Gentamicin—Stomatitis—Capecitabine—prostate cancer	0.000136	0.00113	CcSEcCtD
Gentamicin—Phlebitis—Doxorubicin—prostate cancer	0.000135	0.00112	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—MC2R—prostate cancer	0.000134	0.00144	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RALBP1—prostate cancer	0.000134	0.00144	CbGpPWpGaD
Gentamicin—Agranulocytosis—Docetaxel—prostate cancer	0.000134	0.00111	CcSEcCtD
Gentamicin—LRP2—Disease—HIST1H2BG—prostate cancer	0.000134	0.00144	CbGpPWpGaD
Gentamicin—Confusional state—Mitoxantrone—prostate cancer	0.000134	0.00111	CcSEcCtD
Gentamicin—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000133	0.0011	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	0.000133	0.00142	CbGpPWpGaD
Gentamicin—Hypersensitivity—Goserelin—prostate cancer	0.000132	0.0011	CcSEcCtD
Gentamicin—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000131	0.00109	CcSEcCtD
Gentamicin—LRP2—Metabolism—TBXAS1—prostate cancer	0.000131	0.00141	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTA4—prostate cancer	0.000131	0.00141	CbGpPWpGaD
Gentamicin—Purpura—Epirubicin—prostate cancer	0.000131	0.00108	CcSEcCtD
Gentamicin—Vascular purpura—Doxorubicin—prostate cancer	0.00013	0.00108	CcSEcCtD
Gentamicin—Anaphylactoid reaction—Epirubicin—prostate cancer	0.00013	0.00108	CcSEcCtD
Gentamicin—Agranulocytosis—Capecitabine—prostate cancer	0.00013	0.00108	CcSEcCtD
Gentamicin—Thrombocytopenia—Mitoxantrone—prostate cancer	0.00013	0.00108	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Estradiol—prostate cancer	0.00013	0.00108	CcSEcCtD
Gentamicin—Nausea—Ethinyl Estradiol—prostate cancer	0.00013	0.00108	CcSEcCtD
Gentamicin—LRP2—Disease—HIST1H4H—prostate cancer	0.00013	0.00139	CbGpPWpGaD
Gentamicin—LRP2—Disease—NPPA—prostate cancer	0.00013	0.00139	CbGpPWpGaD
Gentamicin—Hypoaesthesia—Docetaxel—prostate cancer	0.000129	0.00107	CcSEcCtD
Gentamicin—Lethargy—Epirubicin—prostate cancer	0.000129	0.00107	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	0.000128	0.00138	CbGpPWpGaD
Gentamicin—Paraesthesia—Estradiol—prostate cancer	0.000128	0.00106	CcSEcCtD
Gentamicin—LRP2—Metabolism—GSTA2—prostate cancer	0.000128	0.00137	CbGpPWpGaD
Gentamicin—Pruritus—Goserelin—prostate cancer	0.000127	0.00105	CcSEcCtD
Gentamicin—LRP2—Metabolism—SULT1A1—prostate cancer	0.000126	0.00136	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ABCG5—prostate cancer	0.000126	0.00136	CbGpPWpGaD
Gentamicin—Pruritus—Conjugated Estrogens—prostate cancer	0.000126	0.00104	CcSEcCtD
Gentamicin—Weight decreased—Prednisone—prostate cancer	0.000126	0.00104	CcSEcCtD
Gentamicin—Anaemia—Etoposide—prostate cancer	0.000125	0.00104	CcSEcCtD
Gentamicin—Visual impairment—Docetaxel—prostate cancer	0.000124	0.00103	CcSEcCtD
Gentamicin—Hypoaesthesia—Capecitabine—prostate cancer	0.000124	0.00103	CcSEcCtD
Gentamicin—Hypotension—Mitoxantrone—prostate cancer	0.000124	0.00103	CcSEcCtD
Gentamicin—Decreased appetite—Estradiol—prostate cancer	0.000124	0.00103	CcSEcCtD
Gentamicin—LRP2—Metabolism—GSTA1—prostate cancer	0.000123	0.00132	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—HSD3B2—prostate cancer	0.000122	0.00131	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTO1—prostate cancer	0.000122	0.00131	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NAT2—prostate cancer	0.000122	0.00131	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Prednisone—prostate cancer	0.000122	0.00101	CcSEcCtD
Gentamicin—Vertigo—Etoposide—prostate cancer	0.000122	0.00101	CcSEcCtD
Gentamicin—Leukopenia—Etoposide—prostate cancer	0.000121	0.001	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Mitoxantrone—prostate cancer	0.000121	0.001	CcSEcCtD
Gentamicin—Purpura—Doxorubicin—prostate cancer	0.000121	0.001	CcSEcCtD
Gentamicin—Visual impairment—Capecitabine—prostate cancer	0.000121	0.000999	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC22A3—prostate cancer	0.000121	0.0013	CbGpPWpGaD
Gentamicin—Anaphylactoid reaction—Doxorubicin—prostate cancer	0.00012	0.000998	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC7A1—prostate cancer	0.00012	0.00129	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PENK—prostate cancer	0.00012	0.00129	CbGpPWpGaD
Gentamicin—Paraesthesia—Mitoxantrone—prostate cancer	0.000119	0.000988	CcSEcCtD
Gentamicin—Lethargy—Doxorubicin—prostate cancer	0.000119	0.000986	CcSEcCtD
Gentamicin—Dizziness—Goserelin—prostate cancer	0.000119	0.000985	CcSEcCtD
Gentamicin—Dizziness—Conjugated Estrogens—prostate cancer	0.000118	0.000976	CcSEcCtD
Gentamicin—Feeling abnormal—Estradiol—prostate cancer	0.000117	0.000973	CcSEcCtD
Gentamicin—Convulsion—Etoposide—prostate cancer	0.000117	0.000972	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	0.000117	0.00126	CbGpPWpGaD
Gentamicin—Hypertension—Etoposide—prostate cancer	0.000117	0.000968	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP2C18—prostate cancer	0.000117	0.00125	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PLCB2—prostate cancer	0.000117	0.00125	CbGpPWpGaD
Gentamicin—Tinnitus—Capecitabine—prostate cancer	0.000117	0.000967	CcSEcCtD
Gentamicin—Decreased appetite—Mitoxantrone—prostate cancer	0.000115	0.000957	CcSEcCtD
Gentamicin—Hypokalaemia—Epirubicin—prostate cancer	0.000115	0.00095	CcSEcCtD
Gentamicin—LRP2—Metabolism—P4HB—prostate cancer	0.000114	0.00123	CbGpPWpGaD
Gentamicin—Vomiting—Goserelin—prostate cancer	0.000114	0.000947	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—GHR—prostate cancer	0.000114	0.00123	CbGpPWpGaD
Gentamicin—Alopecia—Docetaxel—prostate cancer	0.000114	0.000946	CcSEcCtD
Gentamicin—Rash—Goserelin—prostate cancer	0.000113	0.000939	CcSEcCtD
Gentamicin—Dermatitis—Goserelin—prostate cancer	0.000113	0.000938	CcSEcCtD
Gentamicin—Vomiting—Conjugated Estrogens—prostate cancer	0.000113	0.000938	CcSEcCtD
Gentamicin—Urticaria—Estradiol—prostate cancer	0.000113	0.000938	CcSEcCtD
Gentamicin—Body temperature increased—Estradiol—prostate cancer	0.000113	0.000934	CcSEcCtD
Gentamicin—Headache—Goserelin—prostate cancer	0.000113	0.000933	CcSEcCtD
Gentamicin—Erythema—Docetaxel—prostate cancer	0.000112	0.000932	CcSEcCtD
Gentamicin—Rash—Conjugated Estrogens—prostate cancer	0.000112	0.00093	CcSEcCtD
Gentamicin—Dermatitis—Conjugated Estrogens—prostate cancer	0.000112	0.00093	CcSEcCtD
Gentamicin—Headache—Conjugated Estrogens—prostate cancer	0.000112	0.000924	CcSEcCtD
Gentamicin—LRP2—Metabolism—SLC22A1—prostate cancer	0.000111	0.0012	CbGpPWpGaD
Gentamicin—Confusional state—Etoposide—prostate cancer	0.000111	0.000923	CcSEcCtD
Gentamicin—Muscular weakness—Epirubicin—prostate cancer	0.000111	0.000921	CcSEcCtD
Gentamicin—Hallucination—Prednisone—prostate cancer	0.000111	0.000919	CcSEcCtD
Gentamicin—Alopecia—Capecitabine—prostate cancer	0.000111	0.000916	CcSEcCtD
Gentamicin—Anaphylactic shock—Etoposide—prostate cancer	0.00011	0.000915	CcSEcCtD
Gentamicin—LRP2—Disease—B2M—prostate cancer	0.00011	0.00118	CbGpPWpGaD
Gentamicin—LRP2—Disease—TGFBR1—prostate cancer	0.00011	0.00118	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	0.00011	0.00118	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NRP1—prostate cancer	0.00011	0.00118	CbGpPWpGaD
Gentamicin—Feeling abnormal—Mitoxantrone—prostate cancer	0.000109	0.000907	CcSEcCtD
Gentamicin—Erythema—Capecitabine—prostate cancer	0.000109	0.000902	CcSEcCtD
Gentamicin—LRP2—Metabolism—SULT2A1—prostate cancer	0.000109	0.00117	CbGpPWpGaD
Gentamicin—LRP2—Disease—RPS19—prostate cancer	0.000108	0.00117	CbGpPWpGaD
Gentamicin—LRP2—Disease—AKR1C3—prostate cancer	0.000108	0.00117	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Etoposide—prostate cancer	0.000108	0.000896	CcSEcCtD
Gentamicin—LRP2—Disease—PRKACB—prostate cancer	0.000108	0.00116	CbGpPWpGaD
Gentamicin—Eosinophilia—Epirubicin—prostate cancer	0.000108	0.000893	CcSEcCtD
Gentamicin—Nausea—Goserelin—prostate cancer	0.000107	0.000885	CcSEcCtD
Gentamicin—LRP2—Metabolism—MED12—prostate cancer	0.000107	0.00115	CbGpPWpGaD
Gentamicin—Hypokalaemia—Doxorubicin—prostate cancer	0.000106	0.000879	CcSEcCtD
Gentamicin—LRP2—Metabolism—GNG5—prostate cancer	0.000106	0.00114	CbGpPWpGaD
Gentamicin—Nausea—Conjugated Estrogens—prostate cancer	0.000106	0.000876	CcSEcCtD
Gentamicin—Urticaria—Mitoxantrone—prostate cancer	0.000105	0.000874	CcSEcCtD
Gentamicin—LRP2—Disease—PPP3CA—prostate cancer	0.000105	0.00113	CbGpPWpGaD
Gentamicin—Hypersensitivity—Estradiol—prostate cancer	0.000105	0.00087	CcSEcCtD
Gentamicin—Body temperature increased—Mitoxantrone—prostate cancer	0.000105	0.00087	CcSEcCtD
Gentamicin—Anaemia—Docetaxel—prostate cancer	0.000104	0.000861	CcSEcCtD
Gentamicin—Hypotension—Etoposide—prostate cancer	0.000103	0.000855	CcSEcCtD
Gentamicin—Muscular weakness—Doxorubicin—prostate cancer	0.000103	0.000852	CcSEcCtD
Gentamicin—LRP2—Metabolism—NCOA3—prostate cancer	0.000102	0.0011	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—VIP—prostate cancer	0.000102	0.00109	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GNRH1—prostate cancer	0.000102	0.00109	CbGpPWpGaD
Gentamicin—LRP2—Disease—PRKCZ—prostate cancer	0.000102	0.00109	CbGpPWpGaD
Gentamicin—Pruritus—Estradiol—prostate cancer	0.000101	0.000836	CcSEcCtD
Gentamicin—Leukopenia—Docetaxel—prostate cancer	0.000101	0.000834	CcSEcCtD
Gentamicin—Anaemia—Capecitabine—prostate cancer	0.000101	0.000834	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	0.0001	0.00108	CbGpPWpGaD
Gentamicin—LRP2—Disease—CALR—prostate cancer	9.99e-05	0.00107	CbGpPWpGaD
Gentamicin—Eosinophilia—Doxorubicin—prostate cancer	9.97e-05	0.000827	CcSEcCtD
Gentamicin—Paraesthesia—Etoposide—prostate cancer	9.92e-05	0.000822	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—GRP—prostate cancer	9.86e-05	0.00106	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—LPAR1—prostate cancer	9.86e-05	0.00106	CbGpPWpGaD
Gentamicin—Weight decreased—Epirubicin—prostate cancer	9.85e-05	0.000816	CcSEcCtD
Gentamicin—Alopecia—Prednisone—prostate cancer	9.84e-05	0.000816	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC22A1—prostate cancer	9.82e-05	0.00106	CbGpPWpGaD
Gentamicin—LRP2—Disease—FGFR4—prostate cancer	9.82e-05	0.00106	CbGpPWpGaD
Gentamicin—LRP2—Disease—PARP1—prostate cancer	9.82e-05	0.00106	CbGpPWpGaD
Gentamicin—Vertigo—Capecitabine—prostate cancer	9.78e-05	0.000811	CcSEcCtD
Gentamicin—Hypersensitivity—Mitoxantrone—prostate cancer	9.78e-05	0.000811	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PLCB2—prostate cancer	9.76e-05	0.00105	CbGpPWpGaD
Gentamicin—Leukopenia—Capecitabine—prostate cancer	9.75e-05	0.000808	CcSEcCtD
Gentamicin—Convulsion—Docetaxel—prostate cancer	9.74e-05	0.000808	CcSEcCtD
Gentamicin—LRP2—Metabolism—HPGDS—prostate cancer	9.73e-05	0.00105	CbGpPWpGaD
Gentamicin—Hypertension—Docetaxel—prostate cancer	9.71e-05	0.000805	CcSEcCtD
Gentamicin—LRP2—Disease—CALCA—prostate cancer	9.7e-05	0.00104	CbGpPWpGaD
Gentamicin—Erythema—Prednisone—prostate cancer	9.7e-05	0.000804	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP2C19—prostate cancer	9.67e-05	0.00104	CbGpPWpGaD
Gentamicin—Decreased appetite—Etoposide—prostate cancer	9.6e-05	0.000796	CcSEcCtD
Gentamicin—Arthralgia—Docetaxel—prostate cancer	9.57e-05	0.000794	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CX3CL1—prostate cancer	9.57e-05	0.00103	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—P4HB—prostate cancer	9.57e-05	0.00103	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Epirubicin—prostate cancer	9.51e-05	0.000789	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC39A1—prostate cancer	9.5e-05	0.00102	CbGpPWpGaD
Gentamicin—Stomatitis—Epirubicin—prostate cancer	9.46e-05	0.000784	CcSEcCtD
Gentamicin—LRP2—Metabolism—GSTT1—prostate cancer	9.44e-05	0.00101	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ACHE—prostate cancer	9.44e-05	0.00101	CbGpPWpGaD
Gentamicin—Dizziness—Estradiol—prostate cancer	9.42e-05	0.000781	CcSEcCtD
Gentamicin—Hypertension—Capecitabine—prostate cancer	9.4e-05	0.000779	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—HIST1H2BG—prostate cancer	9.4e-05	0.00101	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CYP2A6—prostate cancer	9.33e-05	0.001	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GRB7—prostate cancer	9.31e-05	0.001	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PDE4D—prostate cancer	9.31e-05	0.001	CbGpPWpGaD
Gentamicin—LRP2—Disease—HSPA1A—prostate cancer	9.3e-05	0.001	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	9.3e-05	0.000999	CbGpPWpGaD
Gentamicin—Arthralgia—Capecitabine—prostate cancer	9.27e-05	0.000768	CcSEcCtD
Gentamicin—Confusional state—Docetaxel—prostate cancer	9.25e-05	0.000767	CcSEcCtD
Gentamicin—Anaphylactic shock—Docetaxel—prostate cancer	9.18e-05	0.000761	CcSEcCtD
Gentamicin—Weight decreased—Doxorubicin—prostate cancer	9.11e-05	0.000755	CcSEcCtD
Gentamicin—Feeling abnormal—Etoposide—prostate cancer	9.1e-05	0.000754	CcSEcCtD
Gentamicin—LRP2—Metabolism—AKR1C3—prostate cancer	9.08e-05	0.000976	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HIST1H4H—prostate cancer	9.07e-05	0.000976	CbGpPWpGaD
Gentamicin—Vomiting—Estradiol—prostate cancer	9.06e-05	0.000751	CcSEcCtD
Gentamicin—Agranulocytosis—Epirubicin—prostate cancer	9.06e-05	0.000751	CcSEcCtD
Gentamicin—LRP2—Metabolism—PRKACB—prostate cancer	9.03e-05	0.000971	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Docetaxel—prostate cancer	8.99e-05	0.000745	CcSEcCtD
Gentamicin—Rash—Estradiol—prostate cancer	8.98e-05	0.000745	CcSEcCtD
Gentamicin—Dermatitis—Estradiol—prostate cancer	8.98e-05	0.000744	CcSEcCtD
Gentamicin—Anaemia—Prednisone—prostate cancer	8.96e-05	0.000743	CcSEcCtD
Gentamicin—Confusional state—Capecitabine—prostate cancer	8.96e-05	0.000743	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP17A1—prostate cancer	8.94e-05	0.000961	CbGpPWpGaD
Gentamicin—Headache—Estradiol—prostate cancer	8.93e-05	0.00074	CcSEcCtD
Gentamicin—LRP2—Disease—CASP9—prostate cancer	8.92e-05	0.000959	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GNG5—prostate cancer	8.86e-05	0.000952	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	8.81e-05	0.000948	CbGpPWpGaD
Gentamicin—Neuropathy peripheral—Doxorubicin—prostate cancer	8.8e-05	0.00073	CcSEcCtD
Gentamicin—Urticaria—Etoposide—prostate cancer	8.77e-05	0.000727	CcSEcCtD
Gentamicin—Stomatitis—Doxorubicin—prostate cancer	8.75e-05	0.000726	CcSEcCtD
Gentamicin—Body temperature increased—Etoposide—prostate cancer	8.73e-05	0.000724	CcSEcCtD
Gentamicin—Vertigo—Prednisone—prostate cancer	8.71e-05	0.000722	CcSEcCtD
Gentamicin—Thrombocytopenia—Capecitabine—prostate cancer	8.7e-05	0.000721	CcSEcCtD
Gentamicin—Hypoaesthesia—Epirubicin—prostate cancer	8.67e-05	0.000719	CcSEcCtD
Gentamicin—LRP2—Disease—PRKCQ—prostate cancer	8.65e-05	0.000929	CbGpPWpGaD
Gentamicin—Hypotension—Docetaxel—prostate cancer	8.58e-05	0.000711	CcSEcCtD
Gentamicin—LRP2—Metabolism—NCOA2—prostate cancer	8.52e-05	0.000915	CbGpPWpGaD
Gentamicin—Nausea—Estradiol—prostate cancer	8.46e-05	0.000701	CcSEcCtD
Gentamicin—Vomiting—Mitoxantrone—prostate cancer	8.44e-05	0.0007	CcSEcCtD
Gentamicin—Convulsion—Prednisone—prostate cancer	8.4e-05	0.000696	CcSEcCtD
Gentamicin—Visual impairment—Epirubicin—prostate cancer	8.4e-05	0.000696	CcSEcCtD
Gentamicin—Agranulocytosis—Doxorubicin—prostate cancer	8.38e-05	0.000695	CcSEcCtD
Gentamicin—Hypertension—Prednisone—prostate cancer	8.37e-05	0.000694	CcSEcCtD
Gentamicin—Rash—Mitoxantrone—prostate cancer	8.37e-05	0.000694	CcSEcCtD
Gentamicin—Dermatitis—Mitoxantrone—prostate cancer	8.36e-05	0.000693	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Docetaxel—prostate cancer	8.36e-05	0.000693	CcSEcCtD
Gentamicin—Headache—Mitoxantrone—prostate cancer	8.32e-05	0.000689	CcSEcCtD
Gentamicin—Hypotension—Capecitabine—prostate cancer	8.3e-05	0.000688	CcSEcCtD
Gentamicin—Arthralgia—Prednisone—prostate cancer	8.26e-05	0.000684	CcSEcCtD
Gentamicin—Paraesthesia—Docetaxel—prostate cancer	8.24e-05	0.000683	CcSEcCtD
Gentamicin—LRP2—Disease—FGF10—prostate cancer	8.21e-05	0.000883	CbGpPWpGaD
Gentamicin—Hypersensitivity—Etoposide—prostate cancer	8.14e-05	0.000674	CcSEcCtD
Gentamicin—Tinnitus—Epirubicin—prostate cancer	8.12e-05	0.000673	CcSEcCtD
Gentamicin—LRP2—Metabolism—SLC5A5—prostate cancer	8.12e-05	0.000873	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Capecitabine—prostate cancer	8.1e-05	0.000671	CcSEcCtD
Gentamicin—Hypoaesthesia—Doxorubicin—prostate cancer	8.02e-05	0.000665	CcSEcCtD
Gentamicin—Paraesthesia—Capecitabine—prostate cancer	7.98e-05	0.000661	CcSEcCtD
Gentamicin—Decreased appetite—Docetaxel—prostate cancer	7.98e-05	0.000661	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP2E1—prostate cancer	7.93e-05	0.000853	CbGpPWpGaD
Gentamicin—Anaphylactic shock—Prednisone—prostate cancer	7.92e-05	0.000656	CcSEcCtD
Gentamicin—Nausea—Mitoxantrone—prostate cancer	7.89e-05	0.000654	CcSEcCtD
Gentamicin—LRP2—Metabolism—NQO1—prostate cancer	7.85e-05	0.000843	CbGpPWpGaD
Gentamicin—LRP2—Disease—TGFBR2—prostate cancer	7.81e-05	0.00084	CbGpPWpGaD
Gentamicin—Pruritus—Etoposide—prostate cancer	7.81e-05	0.000648	CcSEcCtD
Gentamicin—Visual impairment—Doxorubicin—prostate cancer	7.77e-05	0.000644	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—CYP7B1—prostate cancer	7.75e-05	0.000833	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—TH—prostate cancer	7.73e-05	0.000831	CbGpPWpGaD
Gentamicin—Decreased appetite—Capecitabine—prostate cancer	7.72e-05	0.00064	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—TGFBR1—prostate cancer	7.72e-05	0.000829	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTHLH—prostate cancer	7.72e-05	0.000829	CbGpPWpGaD
Gentamicin—Alopecia—Epirubicin—prostate cancer	7.7e-05	0.000638	CcSEcCtD
Gentamicin—LRP2—Disease—ITPR1—prostate cancer	7.69e-05	0.000827	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	7.68e-05	0.000826	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CYP3A4—prostate cancer	7.65e-05	0.000823	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	7.61e-05	0.000818	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AKR1C3—prostate cancer	7.59e-05	0.000816	CbGpPWpGaD
Gentamicin—Erythema—Epirubicin—prostate cancer	7.59e-05	0.000629	CcSEcCtD
Gentamicin—Feeling abnormal—Docetaxel—prostate cancer	7.56e-05	0.000627	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PRKACB—prostate cancer	7.55e-05	0.000812	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC12A2—prostate cancer	7.55e-05	0.000812	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC26A4—prostate cancer	7.55e-05	0.000812	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CYP1B1—prostate cancer	7.52e-05	0.000809	CbGpPWpGaD
Gentamicin—Tinnitus—Doxorubicin—prostate cancer	7.52e-05	0.000623	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—THBS1—prostate cancer	7.36e-05	0.000791	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PPP3CA—prostate cancer	7.36e-05	0.000791	CbGpPWpGaD
Gentamicin—Feeling abnormal—Capecitabine—prostate cancer	7.32e-05	0.000607	CcSEcCtD
Gentamicin—Dizziness—Etoposide—prostate cancer	7.3e-05	0.000605	CcSEcCtD
Gentamicin—LRP2—Metabolism—GGT1—prostate cancer	7.28e-05	0.000783	CbGpPWpGaD
Gentamicin—Body temperature increased—Docetaxel—prostate cancer	7.26e-05	0.000601	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—ANXA1—prostate cancer	7.25e-05	0.00078	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Prednisone—prostate cancer	7.21e-05	0.000598	CcSEcCtD
Gentamicin—LRP2—Metabolism—NCOA1—prostate cancer	7.18e-05	0.000771	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—prostate cancer	7.17e-05	0.00077	CbGpPWpGaD
Gentamicin—Alopecia—Doxorubicin—prostate cancer	7.12e-05	0.00059	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PRKCZ—prostate cancer	7.12e-05	0.000765	CbGpPWpGaD
Gentamicin—Paraesthesia—Prednisone—prostate cancer	7.11e-05	0.000589	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP19A1—prostate cancer	7.07e-05	0.00076	CbGpPWpGaD
Gentamicin—Urticaria—Capecitabine—prostate cancer	7.06e-05	0.000585	CcSEcCtD
Gentamicin—LRP2—Disease—LPL—prostate cancer	7.05e-05	0.000758	CbGpPWpGaD
Gentamicin—Body temperature increased—Capecitabine—prostate cancer	7.02e-05	0.000582	CcSEcCtD
Gentamicin—Vomiting—Etoposide—prostate cancer	7.02e-05	0.000582	CcSEcCtD
Gentamicin—Erythema—Doxorubicin—prostate cancer	7.02e-05	0.000582	CcSEcCtD
Gentamicin—Anaemia—Epirubicin—prostate cancer	7.01e-05	0.000581	CcSEcCtD
Gentamicin—LRP2—Disease—PDGFRB—prostate cancer	6.98e-05	0.000751	CbGpPWpGaD
Gentamicin—Rash—Etoposide—prostate cancer	6.96e-05	0.000577	CcSEcCtD
Gentamicin—Dermatitis—Etoposide—prostate cancer	6.96e-05	0.000577	CcSEcCtD
Gentamicin—Headache—Etoposide—prostate cancer	6.92e-05	0.000573	CcSEcCtD
Gentamicin—Decreased appetite—Prednisone—prostate cancer	6.88e-05	0.00057	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—FGFR4—prostate cancer	6.88e-05	0.000739	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PARP1—prostate cancer	6.88e-05	0.000739	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—RXRA—prostate cancer	6.83e-05	0.000734	CbGpPWpGaD
Gentamicin—Vertigo—Epirubicin—prostate cancer	6.81e-05	0.000565	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CALCA—prostate cancer	6.79e-05	0.00073	CbGpPWpGaD
Gentamicin—Leukopenia—Epirubicin—prostate cancer	6.79e-05	0.000563	CcSEcCtD
Gentamicin—Hypersensitivity—Docetaxel—prostate cancer	6.76e-05	0.00056	CcSEcCtD
Gentamicin—LRP2—Disease—ERCC2—prostate cancer	6.75e-05	0.000726	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	6.64e-05	0.000714	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CXCL12—prostate cancer	6.63e-05	0.000713	CbGpPWpGaD
Gentamicin—LRP2—Disease—ERBB3—prostate cancer	6.6e-05	0.00071	CbGpPWpGaD
Gentamicin—LRP2—Disease—FGFR2—prostate cancer	6.59e-05	0.000709	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—COMT—prostate cancer	6.57e-05	0.000707	CbGpPWpGaD
Gentamicin—Convulsion—Epirubicin—prostate cancer	6.57e-05	0.000545	CcSEcCtD
Gentamicin—Nausea—Etoposide—prostate cancer	6.56e-05	0.000544	CcSEcCtD
Gentamicin—Hypertension—Epirubicin—prostate cancer	6.55e-05	0.000543	CcSEcCtD
Gentamicin—Hypersensitivity—Capecitabine—prostate cancer	6.55e-05	0.000543	CcSEcCtD
Gentamicin—LRP2—Metabolism—GSTP1—prostate cancer	6.54e-05	0.000703	CbGpPWpGaD
Gentamicin—Feeling abnormal—Prednisone—prostate cancer	6.52e-05	0.000541	CcSEcCtD
Gentamicin—Pruritus—Docetaxel—prostate cancer	6.49e-05	0.000538	CcSEcCtD
Gentamicin—Anaemia—Doxorubicin—prostate cancer	6.49e-05	0.000538	CcSEcCtD
Gentamicin—Arthralgia—Epirubicin—prostate cancer	6.46e-05	0.000535	CcSEcCtD
Gentamicin—LRP2—Metabolism—ITPR1—prostate cancer	6.44e-05	0.000692	CbGpPWpGaD
Gentamicin—LRP2—Disease—MTHFR—prostate cancer	6.35e-05	0.000682	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	6.33e-05	0.000681	CbGpPWpGaD
Gentamicin—LRP2—Disease—TERT—prostate cancer	6.33e-05	0.00068	CbGpPWpGaD
Gentamicin—Vertigo—Doxorubicin—prostate cancer	6.31e-05	0.000523	CcSEcCtD
Gentamicin—Urticaria—Prednisone—prostate cancer	6.29e-05	0.000521	CcSEcCtD
Gentamicin—Pruritus—Capecitabine—prostate cancer	6.29e-05	0.000521	CcSEcCtD
Gentamicin—Leukopenia—Doxorubicin—prostate cancer	6.28e-05	0.000521	CcSEcCtD
Gentamicin—Body temperature increased—Prednisone—prostate cancer	6.26e-05	0.000519	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CASP9—prostate cancer	6.25e-05	0.000672	CbGpPWpGaD
Gentamicin—Confusional state—Epirubicin—prostate cancer	6.24e-05	0.000517	CcSEcCtD
Gentamicin—Anaphylactic shock—Epirubicin—prostate cancer	6.19e-05	0.000513	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC22A3—prostate cancer	6.12e-05	0.000658	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—TYMS—prostate cancer	6.08e-05	0.000654	CbGpPWpGaD
Gentamicin—Convulsion—Doxorubicin—prostate cancer	6.08e-05	0.000504	CcSEcCtD
Gentamicin—Dizziness—Docetaxel—prostate cancer	6.07e-05	0.000503	CcSEcCtD
Gentamicin—Thrombocytopenia—Epirubicin—prostate cancer	6.06e-05	0.000502	CcSEcCtD
Gentamicin—Hypertension—Doxorubicin—prostate cancer	6.06e-05	0.000502	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PRKCQ—prostate cancer	6.05e-05	0.000651	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NGFR—prostate cancer	6.05e-05	0.000651	CbGpPWpGaD
Gentamicin—LRP2—Disease—HIF1A—prostate cancer	6.05e-05	0.000651	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTM1—prostate cancer	6.01e-05	0.000646	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MAP3K7—prostate cancer	5.98e-05	0.000643	CbGpPWpGaD
Gentamicin—Arthralgia—Doxorubicin—prostate cancer	5.98e-05	0.000495	CcSEcCtD
Gentamicin—LRP2—Metabolism—LPL—prostate cancer	5.9e-05	0.000635	CbGpPWpGaD
Gentamicin—Dizziness—Capecitabine—prostate cancer	5.88e-05	0.000487	CcSEcCtD
Gentamicin—LRP2—Disease—CAV1—prostate cancer	5.85e-05	0.000629	CbGpPWpGaD
Gentamicin—Vomiting—Docetaxel—prostate cancer	5.84e-05	0.000484	CcSEcCtD
Gentamicin—Hypersensitivity—Prednisone—prostate cancer	5.83e-05	0.000483	CcSEcCtD
Gentamicin—Rash—Docetaxel—prostate cancer	5.79e-05	0.00048	CcSEcCtD
Gentamicin—Hypotension—Epirubicin—prostate cancer	5.78e-05	0.000479	CcSEcCtD
Gentamicin—Dermatitis—Docetaxel—prostate cancer	5.78e-05	0.000479	CcSEcCtD
Gentamicin—Confusional state—Doxorubicin—prostate cancer	5.78e-05	0.000479	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—FGF10—prostate cancer	5.75e-05	0.000618	CbGpPWpGaD
Gentamicin—Headache—Docetaxel—prostate cancer	5.75e-05	0.000477	CcSEcCtD
Gentamicin—Anaphylactic shock—Doxorubicin—prostate cancer	5.73e-05	0.000475	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP1A1—prostate cancer	5.7e-05	0.000613	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ADRB2—prostate cancer	5.69e-05	0.000612	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ERCC2—prostate cancer	5.65e-05	0.000608	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCG5—prostate cancer	5.65e-05	0.000608	CbGpPWpGaD
Gentamicin—Vomiting—Capecitabine—prostate cancer	5.65e-05	0.000468	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Epirubicin—prostate cancer	5.64e-05	0.000467	CcSEcCtD
Gentamicin—Thrombocytopenia—Doxorubicin—prostate cancer	5.61e-05	0.000465	CcSEcCtD
Gentamicin—Rash—Capecitabine—prostate cancer	5.6e-05	0.000464	CcSEcCtD
Gentamicin—Pruritus—Prednisone—prostate cancer	5.6e-05	0.000464	CcSEcCtD
Gentamicin—Dermatitis—Capecitabine—prostate cancer	5.6e-05	0.000464	CcSEcCtD
Gentamicin—Headache—Capecitabine—prostate cancer	5.57e-05	0.000461	CcSEcCtD
Gentamicin—Paraesthesia—Epirubicin—prostate cancer	5.56e-05	0.000461	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—VAV3—prostate cancer	5.55e-05	0.000597	CbGpPWpGaD
Gentamicin—LRP2—Disease—BAD—prostate cancer	5.51e-05	0.000592	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TGFBR2—prostate cancer	5.47e-05	0.000588	CbGpPWpGaD
Gentamicin—Nausea—Docetaxel—prostate cancer	5.45e-05	0.000452	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—ITPR1—prostate cancer	5.38e-05	0.000579	CbGpPWpGaD
Gentamicin—Decreased appetite—Epirubicin—prostate cancer	5.38e-05	0.000446	CcSEcCtD
Gentamicin—Hypotension—Doxorubicin—prostate cancer	5.35e-05	0.000444	CcSEcCtD
Gentamicin—LRP2—Disease—APC—prostate cancer	5.33e-05	0.000573	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—MTHFR—prostate cancer	5.31e-05	0.000571	CbGpPWpGaD
Gentamicin—Nausea—Capecitabine—prostate cancer	5.28e-05	0.000437	CcSEcCtD
Gentamicin—LRP2—Disease—IRS1—prostate cancer	5.27e-05	0.000567	CbGpPWpGaD
Gentamicin—LRP2—Disease—EGF—prostate cancer	5.27e-05	0.000567	CbGpPWpGaD
Gentamicin—Dizziness—Prednisone—prostate cancer	5.23e-05	0.000434	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Doxorubicin—prostate cancer	5.22e-05	0.000433	CcSEcCtD
Gentamicin—LRP2—Metabolism—PPARA—prostate cancer	5.21e-05	0.000561	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IGF1R—prostate cancer	5.15e-05	0.000553	CbGpPWpGaD
Gentamicin—Paraesthesia—Doxorubicin—prostate cancer	5.14e-05	0.000426	CcSEcCtD
Gentamicin—LRP2—Disease—GSK3B—prostate cancer	5.12e-05	0.00055	CbGpPWpGaD
Gentamicin—Feeling abnormal—Epirubicin—prostate cancer	5.1e-05	0.000423	CcSEcCtD
Gentamicin—LRP2—Disease—INS—prostate cancer	5.05e-05	0.000543	CbGpPWpGaD
Gentamicin—Vomiting—Prednisone—prostate cancer	5.03e-05	0.000417	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC22A1—prostate cancer	4.99e-05	0.000537	CbGpPWpGaD
Gentamicin—Rash—Prednisone—prostate cancer	4.99e-05	0.000414	CcSEcCtD
Gentamicin—Dermatitis—Prednisone—prostate cancer	4.99e-05	0.000413	CcSEcCtD
Gentamicin—Decreased appetite—Doxorubicin—prostate cancer	4.98e-05	0.000413	CcSEcCtD
Gentamicin—Headache—Prednisone—prostate cancer	4.96e-05	0.000411	CcSEcCtD
Gentamicin—LRP2—Disease—CREBBP—prostate cancer	4.94e-05	0.000531	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—LPL—prostate cancer	4.94e-05	0.000531	CbGpPWpGaD
Gentamicin—Urticaria—Epirubicin—prostate cancer	4.92e-05	0.000408	CcSEcCtD
Gentamicin—LRP2—Metabolism—CAV1—prostate cancer	4.9e-05	0.000527	CbGpPWpGaD
Gentamicin—Body temperature increased—Epirubicin—prostate cancer	4.89e-05	0.000406	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—PDGFRB—prostate cancer	4.89e-05	0.000526	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ITGB3—prostate cancer	4.77e-05	0.000512	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—GNG5—prostate cancer	4.75e-05	0.00051	CbGpPWpGaD
Gentamicin—Feeling abnormal—Doxorubicin—prostate cancer	4.72e-05	0.000391	CcSEcCtD
Gentamicin—LRP2—Disease—MAP2K1—prostate cancer	4.72e-05	0.000507	CbGpPWpGaD
Gentamicin—Nausea—Prednisone—prostate cancer	4.7e-05	0.00039	CcSEcCtD
Gentamicin—LRP2—Disease—PIK3CD—prostate cancer	4.69e-05	0.000504	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	4.68e-05	0.000503	CbGpPWpGaD
Gentamicin—LRP2—Disease—SERPINE1—prostate cancer	4.64e-05	0.000498	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ERBB3—prostate cancer	4.62e-05	0.000497	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FGFR2—prostate cancer	4.62e-05	0.000496	CbGpPWpGaD
Gentamicin—Hypersensitivity—Epirubicin—prostate cancer	4.56e-05	0.000378	CcSEcCtD
Gentamicin—Urticaria—Doxorubicin—prostate cancer	4.55e-05	0.000377	CcSEcCtD
Gentamicin—Body temperature increased—Doxorubicin—prostate cancer	4.53e-05	0.000375	CcSEcCtD
Gentamicin—LRP2—Disease—FGF2—prostate cancer	4.49e-05	0.000482	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CG—prostate cancer	4.47e-05	0.00048	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TERT—prostate cancer	4.43e-05	0.000476	CbGpPWpGaD
Gentamicin—LRP2—Disease—NOS3—prostate cancer	4.43e-05	0.000476	CbGpPWpGaD
Gentamicin—Pruritus—Epirubicin—prostate cancer	4.38e-05	0.000363	CcSEcCtD
Gentamicin—LRP2—Disease—JAK2—prostate cancer	4.3e-05	0.000462	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HIF1A—prostate cancer	4.24e-05	0.000456	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—INS—prostate cancer	4.23e-05	0.000454	CbGpPWpGaD
Gentamicin—Hypersensitivity—Doxorubicin—prostate cancer	4.22e-05	0.00035	CcSEcCtD
Gentamicin—LRP2—Disease—MDM2—prostate cancer	4.2e-05	0.000451	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CREBBP—prostate cancer	4.14e-05	0.000445	CbGpPWpGaD
Gentamicin—LRP2—Disease—ERBB2—prostate cancer	4.14e-05	0.000445	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—LEP—prostate cancer	4.14e-05	0.000445	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CAV1—prostate cancer	4.1e-05	0.000441	CbGpPWpGaD
Gentamicin—Dizziness—Epirubicin—prostate cancer	4.09e-05	0.000339	CcSEcCtD
Gentamicin—LRP2—Disease—PIK3CB—prostate cancer	4.09e-05	0.000439	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KDR—prostate cancer	4.05e-05	0.000436	CbGpPWpGaD
Gentamicin—Pruritus—Doxorubicin—prostate cancer	4.05e-05	0.000336	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—PRKACB—prostate cancer	4.05e-05	0.000435	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTGS2—prostate cancer	4.05e-05	0.000435	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ESR1—prostate cancer	3.95e-05	0.000425	CbGpPWpGaD
Gentamicin—Vomiting—Epirubicin—prostate cancer	3.94e-05	0.000326	CcSEcCtD
Gentamicin—LRP2—Metabolism—PIK3CD—prostate cancer	3.93e-05	0.000422	CbGpPWpGaD
Gentamicin—Rash—Epirubicin—prostate cancer	3.9e-05	0.000324	CcSEcCtD
Gentamicin—Dermatitis—Epirubicin—prostate cancer	3.9e-05	0.000323	CcSEcCtD
Gentamicin—Headache—Epirubicin—prostate cancer	3.88e-05	0.000321	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—BAD—prostate cancer	3.86e-05	0.000414	CbGpPWpGaD
Gentamicin—LRP2—Disease—CDKN1B—prostate cancer	3.83e-05	0.000412	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—NCOA2—prostate cancer	3.82e-05	0.00041	CbGpPWpGaD
Gentamicin—Dizziness—Doxorubicin—prostate cancer	3.79e-05	0.000314	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—APC—prostate cancer	3.73e-05	0.000401	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CG—prostate cancer	3.73e-05	0.000401	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NOS3—prostate cancer	3.71e-05	0.000398	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IRS1—prostate cancer	3.69e-05	0.000397	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EGF—prostate cancer	3.69e-05	0.000397	CbGpPWpGaD
Gentamicin—Nausea—Epirubicin—prostate cancer	3.68e-05	0.000305	CcSEcCtD
Gentamicin—Vomiting—Doxorubicin—prostate cancer	3.64e-05	0.000302	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—prostate cancer	3.64e-05	0.000392	CbGpPWpGaD
Gentamicin—LRP2—Disease—CTNNB1—prostate cancer	3.62e-05	0.000389	CbGpPWpGaD
Gentamicin—Rash—Doxorubicin—prostate cancer	3.61e-05	0.000299	CcSEcCtD
Gentamicin—Dermatitis—Doxorubicin—prostate cancer	3.61e-05	0.000299	CcSEcCtD
Gentamicin—Headache—Doxorubicin—prostate cancer	3.59e-05	0.000297	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—GSK3B—prostate cancer	3.58e-05	0.000385	CbGpPWpGaD
Gentamicin—LRP2—Disease—CDKN1A—prostate cancer	3.54e-05	0.00038	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—INS—prostate cancer	3.53e-05	0.00038	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTEN—prostate cancer	3.53e-05	0.00038	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CREBBP—prostate cancer	3.46e-05	0.000372	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CB—prostate cancer	3.42e-05	0.000368	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IGF1—prostate cancer	3.42e-05	0.000368	CbGpPWpGaD
Gentamicin—Nausea—Doxorubicin—prostate cancer	3.4e-05	0.000282	CcSEcCtD
Gentamicin—LRP2—Metabolism—PTGS2—prostate cancer	3.39e-05	0.000364	CbGpPWpGaD
Gentamicin—LRP2—Disease—EP300—prostate cancer	3.37e-05	0.000362	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MAP2K1—prostate cancer	3.3e-05	0.000355	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CD—prostate cancer	3.28e-05	0.000353	CbGpPWpGaD
Gentamicin—LRP2—Disease—SRC—prostate cancer	3.27e-05	0.000352	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SERPINE1—prostate cancer	3.25e-05	0.000349	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—NCOA1—prostate cancer	3.22e-05	0.000346	CbGpPWpGaD
Gentamicin—LRP2—Disease—STAT3—prostate cancer	3.16e-05	0.000339	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—FGF2—prostate cancer	3.14e-05	0.000338	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NOS3—prostate cancer	3.1e-05	0.000333	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—RXRA—prostate cancer	3.06e-05	0.000329	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—JAK2—prostate cancer	3.01e-05	0.000324	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PTEN—prostate cancer	2.96e-05	0.000318	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MDM2—prostate cancer	2.94e-05	0.000316	CbGpPWpGaD
Gentamicin—LRP2—Disease—MYC—prostate cancer	2.93e-05	0.000315	CbGpPWpGaD
Gentamicin—LRP2—Disease—TGFB1—prostate cancer	2.93e-05	0.000315	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ERBB2—prostate cancer	2.9e-05	0.000312	CbGpPWpGaD
Gentamicin—LRP2—Disease—EGFR—prostate cancer	2.87e-05	0.000308	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CB—prostate cancer	2.86e-05	0.000308	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—EP300—prostate cancer	2.82e-05	0.000303	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CXCL8—prostate cancer	2.75e-05	0.000296	CbGpPWpGaD
Gentamicin—LRP2—Disease—KRAS—prostate cancer	2.71e-05	0.000291	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CDKN1B—prostate cancer	2.68e-05	0.000289	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CASP3—prostate cancer	2.63e-05	0.000283	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL2—prostate cancer	2.63e-05	0.000282	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CCND1—prostate cancer	2.56e-05	0.000275	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CTNNB1—prostate cancer	2.54e-05	0.000273	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3CA—prostate cancer	2.49e-05	0.000268	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MMP9—prostate cancer	2.49e-05	0.000267	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CDKN1A—prostate cancer	2.48e-05	0.000266	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTEN—prostate cancer	2.47e-05	0.000266	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EP300—prostate cancer	2.36e-05	0.000253	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—PPARA—prostate cancer	2.34e-05	0.000251	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SRC—prostate cancer	2.29e-05	0.000246	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—VEGFA—prostate cancer	2.23e-05	0.00024	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—STAT3—prostate cancer	2.21e-05	0.000238	CbGpPWpGaD
Gentamicin—LRP2—Disease—IL6—prostate cancer	2.21e-05	0.000237	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3CA—prostate cancer	2.09e-05	0.000224	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MYC—prostate cancer	2.05e-05	0.000221	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TGFB1—prostate cancer	2.05e-05	0.00022	CbGpPWpGaD
Gentamicin—LRP2—Disease—AKT1—prostate cancer	2.03e-05	0.000219	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EGFR—prostate cancer	2.01e-05	0.000216	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—KRAS—prostate cancer	1.9e-05	0.000204	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—CREBBP—prostate cancer	1.86e-05	0.0002	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3CA—prostate cancer	1.74e-05	0.000187	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—AKT1—prostate cancer	1.7e-05	0.000183	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TP53—prostate cancer	1.69e-05	0.000181	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL6—prostate cancer	1.54e-05	0.000166	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AKT1—prostate cancer	1.42e-05	0.000153	CbGpPWpGaD
